We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+8.58%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.59B
AUM Growth
+$160M
Cap. Flow
-$54.6M
Cap. Flow %
-3.43%
Top 10 Hldgs %
16.55%
Holding
226
New
31
Increased
63
Reduced
63
Closed
27

Top Buys

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$19M
2
OMIC
Singular Genomics Systems, Inc. Common Stock
OMIC
+$16.3M
3
AMRS
Amyris Inc.
AMRS
+$14.3M
4
ESTA icon
Establishment Labs
ESTA
+$12.8M
5
SQSP
Squarespace, Inc.
SQSP
+$9.51M

Top Sells

Rank Stock Value
1
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$20M
2
NVCR icon
NovoCure
NVCR
+$14.8M
3
SEER icon
Seer Inc
SEER
+$14.5M
4
JBLU icon
JetBlue
JBLU
+$14.2M
5
AXSM icon
Axsome Therapeutics
AXSM
+$7.85M

Sector Composition

Rank Sector Weight
1 Healthcare 44.51%
2 Technology 13.21%
3 Financials 6.93%
4 Consumer Discretionary 6.6%
5 Industrials 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PPLI
176
People Inc
PPLI
$3.1B
– –
-47,959
Closed -$5.66M
JBLU icon
177
JetBlue
JBLU
$2.29B
– –
-698,642
Closed -$14.2M
LUV icon
178
Southwest Airlines
LUV
$23B
– –
-94,250
Closed -$5.75M
LVS icon
179
Las Vegas Sands
LVS
$29.6B
– –
-63,530
Closed -$3.86M
MLCO icon
180
Melco Resorts & Entertainment
MLCO
$2.14B
– –
-295,425
Closed -$5.88M
REAL icon
181
The RealReal
REAL
$1.5B
– –
-119,412
Closed -$2.7M
SAIA icon
182
Saia
SAIA
$9.72B
– –
-3,635
Closed -$838K
SEER icon
183
Seer Inc
SEER
$120M
– –
-289,989
Closed -$14.5M
TREX icon
184
Trex
TREX
$5.01B
– –
-33,253
Closed -$3.04M
VAC icon
185
Marriott Vacations Worldwide
VAC
$4.25B
– –
-1,369
Closed -$238K
VC icon
186
Visteon
VC
$2.78B
– –
-15,599
Closed -$1.9M
DCPH
187
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
– –
-446,674
Closed -$20M
AFIB
188
DELISTED
Acutus Medical Inc
AFIB
– –
-145,079
Closed -$1.94M
FST
189
DELISTED
FAST Acquisition Corp.
FST
– –
-58,688
Closed -$735K
GNOG
190
DELISTED
Golden Nugget Online Gaming, Inc. Class A Common Stock
GNOG
– –
-81,116
Closed -$1.09M
RDS.B
191
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
– –
-175,000
Closed -$6.45M
4 5 6 7
8

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Nicholas Investment Partners held 226 positions worth $1.59B, up 11% from $1.43B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Nicholas Investment Partners withdrew a net $54.6M in Q2 2021, closing 27 positions and reducing 63 holdings. Its most notable exit was Deciphera Pharmaceuticals, Inc. Common Stock, an estimated $20M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 48% a quarter earlier, followed by Technology and Financials.

Against the trend, Nicholas Investment Partners opened a new position in Mirati Therapeutics, Inc. Common Stock worth $19.2M.

  • Nicholas Investment Partners's largest Q2 2021 buy was Mirati Therapeutics, Inc. Common Stock: 118,591 shares worth $19.2M.
  • Nicholas Investment Partners added most to Amyris Inc. in Q2 2021, an estimated $14.3M increase.
  • Nicholas Investment Partners's biggest Q2 2021 reduction was NovoCure, cutting an estimated $14.8M.
  • Nicholas Investment Partners fully exited Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2021, selling an estimated $20M.
  • Nicholas Investment Partners's ten largest holdings make up 17% of its $1.59B portfolio in Q2 2021.
  • Nicholas Investment Partners opened 31 new positions and closed 27 in Q2 2021.
  • Nicholas Investment Partners's portfolio value rose 11% quarter-over-quarter to $1.59B.

Based on Nicholas Investment Partners's 13F filing for Q2 2021, filed 10 Aug 2021.